Rabbit Polyclonal TSTA3 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human GFUS aa 150 to C-terminus.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
WB | |
---|---|
Human | Tested |
Mouse | Predicted |
Rat | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/3000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Select an associated product type
Catalyzes the two-step NADP-dependent conversion of GDP-4-dehydro-6-deoxy-D-mannose to GDP-fucose, involving an epimerase and a reductase reaction.
SDR4E1, TSTA3, GFUS, GDP-L-fucose synthase, Protein FX, Red cell NADP(H)-binding protein, Short-chain dehydrogenase/reductase family 4E member 1
Rabbit Polyclonal TSTA3 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human GFUS aa 150 to C-terminus.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
Trans-sialidase-related protein 3 (TSTA3) also known as GDP-L-fucose synthase is an enzyme responsible for converting GDP-4-keto-6-deoxy-D-mannose to GDP-L-fucose an important step in fucose synthesis. TSTA3 has a molecular mass of approximately 36 kDa. This protein expresses widely with significant expression in tissues like the liver which is a central site for metabolic processes.
TSTA3 plays a role in fucosylation a fundamental process for the modification of glycoproteins and glycolipids. Fucosylation affects cellular recognition and signaling events. TSTA3 functions independently and as part of no known physical complex but influences several biological activities indirectly through its enzymatic product GDP-L-fucose. This product is critical in multiple cellular functions and structural carbohydrate assemblies.
TSTA3 participates in the GDP-L-fucose biosynthesis pathway an essential route for the production of fucose necessary for fucosylation processes. This pathway ties directly to protein interactions involving glycosyltransferases such as fucosyltransferases which facilitate the transfer of fucose to glycoproteins and glycolipids. TSTA3's contribution to these pathways affects cell adhesion and immune response signaling.
TSTA3 relates mainly to cancers and congenital disorders of glycosylation. Abnormal fucosylation patterns often due to altered TSTA3 activity have been linked to various cancers impacting proteins like E-selectin which is involved in leukocyte adhesion. Additionally congenital disorders of glycosylation sometimes result from deficiencies in enzymes such as TSTA3 leading to disrupted glycan synthesis and presentation connecting to proteins such as glycoproteins with critical physiological roles.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
10% SDS PAGE
All lanes: Western blot - Anti-TSTA3 antibody (ab155306) at 1/1000 dilution
Lane 1: H1299 whole cell lysate at 30 µg
Lane 2: HeLa whole cell lysate at 30 µg
Predicted band size: 36 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com